Permits for animal studies
The PDF's of the CCD permits are grouped per year
-
2023
AVD202216579: Evaluation of therapies for the treatment of multiple sclerosis
NTS Appendix 1 Appendix 2
-
2022
AVD202215768: Validation and optimization of newly developed PET tracers for human use
Please note that the majority of these documents is in Dutch.
-
2021
AVD202114680: Evaluation of novel influenza vaccine candidates for immunogenicity and capacity to protect against influenza infection in macaques
NTS Project Appendix 1 Appendix 2
AVD202115282: Evaluation of safety and immunogenicity in rhesus macaques of a therapeutic vaccine for treatment of HER2 positive tumours in humans
NTS Projectvoorstel Appendix Decision
AVD202115697: Brain and Blood PK assessment of VNAR antibody-based blood brain barrier shuttle
NTS Project Appendix 1 Appendix 2
Please note that the majority of these documents is in Dutch.
-
2020
AVD20197924: Pre-clinical PK/PD evaluation in non-human primates of immunotherapeutics aimed to induce regulatory T-cells
Answer to questions Additional questions Decision
AVD20209247: Neonatal BCG vaccination in rhesus monkeys as a model for human neonatal BCG vaccination
NTS Project proposal Appendix Decision
AVD20209404: Research into the efficacy of vaccines and antivirals against new coronaviruses
NTS | Project proposal | Appendix
Answer to questions Additional questions Decision
AVD20209464: Testing a new adjuvant, with fewer or no side effects, to model autoimmune diseases of the brain in rhesus monkeys
NTS Project proposal Appendix Decision
AVD202010886: The efficacy of long-acting antibiotics in macaques
AVD202011789: Define optimal injection strategy of an antisense oligonucleotide (ASO) for Angelman Syndrome
NTS | Project proposal | Appendix
Answer to questions Suspension letter Decision
Please note that the majority of these documents is in Dutch.